Document is current
Any future updates will be listed below
-
Authors
Wedel, Saskia
Hahnefeld, Lisa
Schreiber, Yannick
Namendorf, Christian
Heymann, Tim
Uhr, Manfred
Schmidt, Mathias V.
de Bruin, Natasja
Hausch, Felix
Thomas, Dominique
Geisslinger, Gerd
Sisignano, Marco
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB1039 A09, SFB1039 Z01, 445757098)
Bundesministerium für Bildung und Forschung (51TaValP)
Fraunhofer-Institut für Translationale Medizin und Pharmakologie (Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Foundation Project Neuropathic Pain)
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 25 April 2023
Accepted: 16 June 2023
First Online: 24 June 2023
Declarations
:
: All experiments involving animals were approved by the local Ethics Committee for Animal Research (Darmstadt) under the permit numbers F152/1021, F152/1015 and FK1113. Furthermore, all animal experiments were performed according to the recommendations of the Preclinical Pain Research Consortium for Investigating Safety and Efficacy (PPRECISE) Working Group [], and according to the updated ARRIVE guidelines for reporting animal research []. All efforts were made to minimize suffering.
: Not applicable.
: The authors declare that they have no competing interests.
